Icosavax (NASDAQ:ICVX) Hits New 52-Week Low at $16.73

Icosavax Inc (NASDAQ:ICVX) shares reached a new 52-week low during trading on Thursday . The stock traded as low as $16.73 and last traded at $16.73, with a volume of 95 shares traded. The stock had previously closed at $17.59.

Separately, Zacks Investment Research raised Icosavax from a “sell” rating to a “hold” rating in a research report on Friday, December 31st. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $48.57.

The business has a 50-day moving average of $23.07.

Icosavax (NASDAQ:ICVX) last released its quarterly earnings results on Monday, November 15th. The company reported ($1.30) EPS for the quarter, missing the consensus estimate of ($0.49) by ($0.81). The business had revenue of $1.83 million during the quarter, compared to the consensus estimate of $3.30 million. As a group, research analysts expect that Icosavax Inc will post -3.5 EPS for the current year.

Several large investors have recently added to or reduced their stakes in the company. Perceptive Advisors LLC acquired a new position in shares of Icosavax in the third quarter valued at approximately $56,888,000. American International Group Inc. acquired a new position in Icosavax during the third quarter worth $217,000. Bank of New York Mellon Corp acquired a new position in Icosavax during the third quarter worth $965,000. Laurion Capital Management LP acquired a new position in Icosavax during the third quarter worth $22,193,000. Finally, Metropolitan Life Insurance Co NY acquired a new position in Icosavax during the third quarter worth $118,000. 66.13% of the stock is currently owned by institutional investors and hedge funds.

About Icosavax (NASDAQ:ICVX)

Icosavax Inc is a biopharmaceutical company which focuses on life-threatening respiratory diseases. The company’s virus-like particle platform technology involved in developing vaccines against infectious diseases. Icosavax Inc is based in SEATTLE.

Recommended Story: Most Volatile Stocks

Receive News & Ratings for Icosavax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icosavax and related companies with MarketBeat.com's FREE daily email newsletter.